FDA Drug recall D-0709-2021
HYDROMORPHONE HCL-BUPIVACAINE HCL-CLONIDINE HCL PF INJECTABLE 21 mL syringes in two strengths: a) 20MG-20MG-60MCG/ML INJECTABLE, b) 5MG-5MG…
- FDA Drug
- Class I
- terminated
- Published 2021-08-18
On 2021-08-18 the FDA classified a Class I recall of HYDROMORPHONE HCL-BUPIVACAINE HCL-CLONIDINE HCL PF INJECTABLE 21 mL syringes in two strengths: a) 20MG-20MG-60MCG/ML INJECTABLE, b) 5MG-5MG… by Med Shop Total Care, citing non-Sterility.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0709-2021 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2020-10-05 |
| Published | 2021-08-18 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Med Shop Total Care |
| Distribution | PR, TX |
Product
HYDROMORPHONE HCL-BUPIVACAINE HCL-CLONIDINE HCL PF INJECTABLE 21 mL syringes in two strengths: a) 20MG-20MG-60MCG/ML INJECTABLE, b) 5MG-5MG-100MCG/ML, Rx only, Med Shop Total Care 470 East Loop 281 Longview, TX 75605
Reason
Non-Sterility
Identifiers
| code_info | Lot #: a) 09302020@30, BUD 10/23/2020, b) 10022020@14, BUD 10/30/2020 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0709-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.